NattoPharma Signs Agreement with Nutriangels, Expands MenaQ7 Brazil Presence

63387064-1aac-4b69-9b6a-a39c0cd6cf5darticleimage.jpg

16 Jun 2017 --- NattoPharma has announced a new partnership with Nutriangels, a Brazilian nutraceutical brand with products that include chelated minerals, further expanding the presence of MenaQ7 Vitamin K2 as MK-7 in Brazil. The company reports that Nutriangels launched K2 + featuring MenaQ7 in Q2 2017, adding that the product has already been well received. K2 + is positioned to support both bone and cardiovascular health. 

“Brazil is a burgeoning market where NattoPharma already enjoys an established presence. Nutriangels is one of the new pioneering supplement brands serving Brazil and we are thrilled to see this new customer expand our MenaQ7 offering with consumer-targeted, science-based products,” says Eric Anderson, Senior Vice President of Global Sales and Marketing with NattoPharma. 

Click to Enlarge“This milestone marks a welcome increase in awareness of the importance of Vitamin K2 for human health, and the global recognition that MenaQ7 is the clinically validated branded Vitamin K2 as MK-7 of choice,” Anderson says. 

Earlier this week, NattoPharma highlighted the results of a study on the link between low vitamin K2 status and increased risk of fracture in children.

“NattoPharma's clinical trials with adult and child populations have shown that children have the greatest need for vitamin K2, as their bones are growing and developing so intensely, and [the trials have] confirmed that just 45mcg daily of MenaQ7 Vitamin K2 had a profound impact on children's bone health,” Kate Quackenbush, NattoPharma’s Director of Communications, told NutritionInsight.

Regarding the application opportunities for K2, Quackenbush says the company’s “ultimate goal is to see MenaQ7 Vitamin K2 as MK-7 as a core nutrient in all multivitamins, but in particular for kids and prenatal multis that provide a sound foundation for health as early as possible.”

“From a claims perspective, in Europe, due to EFSA regulations, health claims must be applied for and awarded. We are hopeful that this will occur in the coming years. However, given EFSA's recent performance, this is yet to be seen,” she adds.

“In other parts of the world, the regulatory guidelines are different. Regardless, one must have scientific substantiation in the body of evidence that validates the claim. NattoPharma has extensive research including in vitro, in vivo and 16 published human studies (with more underway), that clearly demonstrate the mechanism of vitamin K2 and the subsequent real health benefits such as preserving bone health and mass, and preserving arterial flexibility,” Quackenbush states.

To contact our editorial team please email us at editorial@cnsmedia.com

NattoPharma ASA

Collapse

As the leader in Vitamin K2 research & development, NattoPharma has not only created the Vitamin K2 category, but continues to drive it forward. Offering the best and first clinically validated and patented Vitamin K2 as MK-7 on the market, MenaQ7®, NattoPharma has sponsored the groundbreaking research that has confirmed K2’s essential role in bone and cardiovascular health, for old and young alike.

NattoPharma’s mission is to advance global health by creating and introducing to the market scientifically validated products and technologies that will deliver measurable health benefits and optimal health outcomes.

This mission is accomplished by:

• Addressing significant health concerns with branded, scientifically validated, proprietary products and technologies, leading with our flagship brand MenaQ7®;

• Leveraging all manner of technology to more effectively and efficiently deliver these products to our target markets;

• Solidifying ourselves as the experts in the science underlying our products and associated enabling technologies that allow us to effectively deliver them to the marketplace; and

• Developing and maintaining a deep customer and segment understanding of the benefits we deliver.

With 19+ published studies and even more underway, NattoPharma has an unparalleled patent portfolio related to relevant health benefits and market segments, creating extra values for its customers.  

MenaQ7® meets the growing demand for highly pure, stable K2 for supplemental and food use in any different format.

The most comprehensive Vitamin K2 ingredient portfolio meeting market needs:

MenaQ7® Natural MK-7: 96% pure all-trans MK-7 free of soy and other allergens.

MenaQ7® PharmaPure MK-7: The only all-trans nature-identical synthetic, winner of 2015   NutrAward for Best Functional Ingredient

MenaQ7® Natto MK-7: 96% active all-trans soy fermented MK-7

MenaQ7® Full Spectrum K2: The first and only K2 to deliver menaquinone isomers MK-6, 7, 8, and 9, free from soy and other allergens.

All material is available with CryoCap microencapsulation, ensuring stable menaquinone protection in any formulation.

The MenaQ7® brand is built upon 6 Pillars of Excellence, a platform delivering the most safe and efficacious Vitamin K2 on the market, creating opportunities for manufacturers and value for end users:

• Trusted Expertise

• Science Leader

• Superior Products

• Continuous Innovation

• Educational Marketing

• Cooperative Support

Visit website for more information: www.menaq7.com 

Related Articles

Nutrition & Health News

Weekly Digest: NP Nutra triples its warehouse space, broccoli named US top vegetable

15 Jun 2018 --- This week in nutrition, research studies affirmed the benefit of vitamin K2 for healthy bones, vitamin E tocotrienol may delay paralysis associated with Alzheimers and vegetables took center stage in the US with a survey identifying broccoli as the nations favorite and large investments were made in school plant-based cafeteria options. At a sports nutrition conference, Nitrosamines positive effects on cognitive function were announced, while National Institutes of Health launched a new app aimed at providing safe information on popular herbs. Concerning expansions, NP Nutra expanded its warehouse in California and Azelis opened a new pharmaceutical manufacturing facility in Germany.

Nutrition & Health News

The right nutrition for the golden years: Space for personalization

11 Jun 2018 --- Medical interventions and overall improved standards of living are causing us to live longer than previous generations. However, since the aging process is accompanied by a host of physiological changes, extra attention needs to be given to the appropriate nutrition and lifestyle standards. NutritionInsight speaks with a number of key suppliers about the unique needs of aging consumers.

Nutrition & Health News

Weekly Digest: Plant-based diet boosts healthy hearts, GMP registration for OmniActive health ingredients plant

08 Jun 2018 --- This week in nutrition, OmniActive has had its Hosur plant, that manufactures natural extracts, gain Good Manufacturing Practice (GMP) from NSF and Omya International had its orally disintegrating tablets confirmed by a scientific study. The benefits of a plant-based diet for a healthy heart were touted by researchers, including lower cholesterol and blood pressure. Lastly, NattoPharma and its pharmaceutical spin-off Kaydence Pharma appointed new CEO's amid positive growth results and Lycored appoints a new SVP as it seeks to grow R&D capabilities.

Nutrition & Health News

Sunshine vitamin: Link between low cholesterol and vitamin D in kids, study finds

07 Jun 2018 --- There is a link between higher serum vitamin D levels and lower plasma cholesterol levels in children aged between six and eight years old, research from the University of Eastern Finland has found. The findings, published in the Journal of Clinical Endocrinology and Metabolism, provide support for the importance of adequate vitamin D intake in children.

Nutrition & Health News

NattoPharma spearheads vitamin K2 RDI program

04 Jun 2018 --- Norway-based biotech company NattoPharma has enlisted its research partners to start a program to establish what the company says is a much-needed Recommended Daily Intake (RDI) for vitamin K2. 

More Articles
URL : http://www.nutritioninsight.com:80/news/nattopharma-signs-agreement-with-nutriangels-expands-menaq7-brazil-presence.html